Though the changes in the cardiometabolic risk factors as defined by blood-related parameters were rather modest in our study, it would be interesting to observe whether the magnitude of such changes would be bigger in a cohort with more advance-staged obesity-related comorbidities with higher initial HbA1c, ALT and AST levels. The gene discussed is GPT; the disease is Obesity.